ST JUDE MEDICAL AKTIE | Aktienkurs | Nachrichten | Kurs

DAX	8.305	-0,6%	Dow	15.303	0,1%	Euro	1,2940	0,0%
ESt50	2.764	-0,5%	Nas	3.459	0,0%	Öl	102,6	0,0%
TDax	958,0	-0,3%	Nikkei	14.613	0,9%	Gold	1.387	-0,3%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News	Bilanz/GuV	Dividende/HV	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Schätzungen	Termine	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele	Vergleich	Profil	Knock-Outs	myHome
Orderbuch	Realtime Stuttgart	Fundamentalanalyse		Insidertrades	Fonds	Senden/Drucken
Historisch	Realtime Push	myNews		im Forum	Anleihen

Börse
	34,81 861 Bidsize	34,99 580 Asksize	Zeit:	24.05.13
Push aktivieren

Relevant
Alle
vom Unternehmen
Peer Group
Twitter

Sprache:
Alle
DE
EN
Reload

Sortieren:
Datum
meistgelesen

23.05.13	St Jude Medical EnligHTN Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction (EN, Benzinga asset-sales)
23.05.13	One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology (EN, MotleyFool)
21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
08.05.13	St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)

23.05.13	St Jude Medical EnligHTN Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction (EN, Benzinga asset-sales)
23.05.13	One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology (EN, MotleyFool)
21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
08.05.13	St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)

Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv

17.10.12	St. Jude Medical: Bereinigter Gewinn zieht an (Aktiencheck)
18.07.12	St. Jude Medical: Gewinn im zweiten Quartal zieht an (Aktiencheck)

23.05.13	St Jude Medical EnligHTN Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction (EN, Benzinga asset-sales)
23.05.13	One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology (EN, MotleyFool)
21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
08.05.13	St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)

17.10.12	St. Jude Medical: Bereinigter Gewinn zieht an (Aktiencheck)
18.07.12	St. Jude Medical: Gewinn im zweiten Quartal zieht an (Aktiencheck)
18.07.12	DAX schließt nach guten US-Immobiliendaten weit im Plus -- US-Börsen klettern nach oben -- PayPal treibt eBay an -- IBM-Gewinn oberhalb der Erwartungen -- Bank of America, PUMA, Yahoo im Fokus (finanzen.net)
26.06.12	Diese Top-Trendaktien vom US-Markt bilden Swing Trading-Setups! (finanzen.net)

23.05.13	St Jude Medical EnligHTN Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction (EN, Benzinga asset-sales)
23.05.13	One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology (EN, MotleyFool)
21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
08.05.13	St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)

Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv

21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)
30.04.13	St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker (EN, MotleyFool)
02.05.13	St. Jude Medical Announces Second Quarter Dividend (EN, MotleyFool)
02.05.13	St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)

Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar

21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)
30.04.13	St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker (EN, MotleyFool)
02.05.13	St. Jude Medical Announces Second Quarter Dividend (EN, MotleyFool)
02.05.13	St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)

21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)
30.04.13	St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker (EN, MotleyFool)
02.05.13	St. Jude Medical Announces Second Quarter Dividend (EN, MotleyFool)
02.05.13	St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)

Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar

21.05.13	St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference (EN, MotleyFool)
06.05.13	St. Jude Medical Gets Too Much Praise (EN, TheStreet.com)
09.05.13	St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013 (EN, MotleyFool)
03.05.13	St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference (EN, MotleyFool)
30.04.13	St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker (EN, MotleyFool)
02.05.13	St. Jude Medical Announces Second Quarter Dividend (EN, MotleyFool)
02.05.13	St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study (EN, MotleyFool)
16.05.13	St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement (EN, MotleyFool)

Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden
Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören
Twitter: Tweets mit dem Cashtag des Unternehmens

mehr St Jude Medical News

RSS Feed

St Jude Medical zu myNews hinzufügen Was ist das?

Kurszeit	08:02:29	Kursdatum	24.05.2013
Tageshoch	34,86	Eröffnung	34,86
Tagestief	34,86	Vortag	35,29
52 W. Hoch	36,60	Volumen (Stück)	n/a
52 W. Tief	23,80	Marktkapitalisierung (EUR)	9,89 Mrd.
52 W. Performance		Börse	FSE

Kurszeit	22:15:05	Kursdatum	24.05.2013
Tageshoch	45,43	Eröffnung	44,86
Tagestief	44,60	Vortag	45,17
52 W. Hoch	47,45	Volumen (Stück)	342.028
52 W. Tief	30,25	Marktkapitalisierung (USD)	12,79 Mrd.
52 W. Performance		Börse	NYSE

21.11.12	St Jude Medical sector perform	RBC Capital Markets
20.11.12	St Jude Medical hold	Stifel, Nicolaus & Co., Inc.
14.11.12	St Jude Medical hold	Jefferies & Company Inc.
30.10.12	St Jude Medical equal-weight	Morgan Stanley
21.08.12	St Jude Medical buy	UBS AG

21.08.12	St Jude Medical buy	UBS AG
21.05.12	St Jude Medical overweight	Barclays Capital
14.05.12	St Jude Medical overweight	Barclays Capital
20.04.12	St Jude Medical overweight	Barclays Capital
12.04.12	St Jude Medical overweight	Barclays Capital

21.11.12	St Jude Medical sector perform	RBC Capital Markets
20.11.12	St Jude Medical hold	Stifel, Nicolaus & Co., Inc.
14.11.12	St Jude Medical hold	Jefferies & Company Inc.
30.10.12	St Jude Medical equal-weight	Morgan Stanley
20.07.12	St Jude Medical sector perform	RBC Capital Markets

Finanzen.net

St Jude Medical Aktie [WKN: 864096 / ISIN: US7908491035]

Realtimekurs St. Jude Medical Inc. in Euro

Aktienkurs St. Jude Medical Inc. in EUR

Aktienkurs St. Jude Medical Inc. in USD

Nachrichten zu St. Jude Medical Inc.

Analysen zu St. Jude Medical Inc.

Profil St. Jude Medical Inc.

St Jude Medical CHART - 1 Jahr - FSE

ANZEIGE

Chartsignale St Jude Medical Aktie

Rating St Jude Medical Aktie:

Fundamentalkennzahlen St Jude Medical Aktie in USD

Kursziele St Jude Medical Aktie

Kennzahlen St Jude Medical Aktie

Historische Kurse St Jude Medical Aktie

Peer Group St Jude Medical Aktie

Zur Aktie St Jude Medical

Zum Unternehmen St Jude Medical

Aktien gleicher Branche mit besserer 1J Perf.

Passende Fonds

12.12.11	St Jude Medical sell	Citigroup Corp.
01.12.11	St Jude Medical sell	Citigroup Corp.
05.10.11	St Jude Medical sell	Citigroup Corp.
13.01.11	St Jude Medical sell	Citigroup Corp.
20.09.07	St. Jude Medical sell	UBS AG

GD 38		GD 50
GD 100		GD 200
Momentum trend		Bollinger Band
letztes Signal: neues 4-Wochen Hoch (22.05.2013)

	2012 Bei Fiskaljahresende	2013e	2014e	2015e
Dividende	0,91	0,98	1,03	1,09	-
Dividenden- rendite (in %)	2,56	2,35	2,46	2,60	-
Ergebnis/Aktie	3,48	3,69	3,94	4,25	-
KGV	10,25	11,32	10,62	9,85

Marktkapitalisierung in Mrd. EUR	9,89
Streubesitz %	67,06
Anzahl Aktien in Mio.	283,36
Cashflow/Aktie	4,26
Buchwert/Aktie	13,22
60 Tage Vola	22,92
KBV	3,41

24.05.2013	34,86
23.05.2013	35,29
22.05.2013	36,14
21.05.2013	36,60	450
20.05.2013	36,50

Boston Scientific	7,0	+2,1%
CR Bard	81,3	-0,3%
Edwards Lifesciences	50,9	+2,7%
Fresenius Medical Care	53,1	-1,0%
Fresenius	94,5	-0,9%
Intuitive Surgical	386,8	+5,8%
Medtronic	39,1	-1,6%
St Jude Medical	34,9	-1,2%

WKN	864096
ISIN	US7908491035
Deutsches Symbol	JUD
Ausländisches Symbol	STJ
Indizes	S&P 500

Land	USA
Branchen	Medizinische Produkte / Medizintechnik
Letzte Dividende	0,25 (Landeswährung)

Orthovita	+75,3%
Fisher Scientific International	+64,0%
Boston Scientific	+50,8%
JohnsonJohnson	+34,8%
Baxter International	+34,5%

Name	Vol. in Mio.
Variopartner SICAV - MIV Global Medtech Fund P1 (CHF)	97
Baring Europa Fund (USD)	67
KBC Equity Fund High Dividend North America (thes.)	26
Performa Fund - Asian Equities	25